Invesco
BNGO icon

Invesco’s Bionano Genomics BNGO Stock Holding History

Invesco’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-371
Closed -$42K – 3871
2023
Q4 		$42K Sell
371
-138
-27% -$14.4K ﹤0.01% 3758
2023
Q3 		$92.5K Buy
509
+66
+15% +$17.3K ﹤0.01% 3727
2023
Q2 		$162K Sell
443
-146
-25% -$65.9K ﹤0.01% 3658
2023
Q1 		$392K Buy
589
+382
+185% +$339K ﹤0.01% 3406
2022
Q4 		$181K Buy
207
+22
+12% +$27.7K ﹤0.01% 3713
2022
Q3 		$203K Sell
185
-13
-7% -$17.2K ﹤0.01% 3677
2022
Q2 		$165K Sell
198
-22
-10% -$22.6K ﹤0.01% 3778
2022
Q1 		$339K Buy
220
+5
+2% +$6.75K ﹤0.01% 3579
2021
Q4 		$386K Sell
215
-53
-20% -$142K ﹤0.01% 3497
2021
Q3 		$883K Buy
268
+56
+26% +$196K ﹤0.01% 3163
2021
Q2 		$934K Sell
212
-6,775
-97% -$26.7M ﹤0.01% 3143
2021
Q1 		$33.9M Buy
+6,987
New +$39.4M 0.01% 1240

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco's BNGO Position: Q1 2024 in Review

Invesco sold out of Bionano Genomics (BNGO) in Q1 2024, closing a stake of 371 shares — an estimated $42K sold.

Invesco first reported a position in BNGO in Q1 2021 and held it in 12 quarters. The position peaked at $33.9M in Q1 2021. 55 funds tracked by Wall St. Rank hold BNGO as of Q1 2024.

  • Invesco reported no remaining Bionano Genomics position as of Q1 2024 after selling out during the quarter.
  • Invesco sold 371 Bionano Genomics shares in Q1 2024, an estimated $42K.
  • Invesco first reported a position in Bionano Genomics in Q1 2021 and held it in 12 quarters.
  • Invesco's Bionano Genomics position peaked at $33.9M in Q1 2021.
  • 55 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2024.

Based on Invesco's 13F filing for Q1 2024, filed 14 May 2024.